Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Feb;4(1):6-12.

Effectiveness of a single topical application of 10|x% trolamine salicylate cream in the symptomatic treatment of osteoarthritis

Affiliations
  • PMID: 19078236

Effectiveness of a single topical application of 10|x% trolamine salicylate cream in the symptomatic treatment of osteoarthritis

D Q Rothacker et al. J Clin Rheumatol. 1998 Feb.

Abstract

This study was designed to evaluate the effectiveness in relief of pain and rigidity of a 10|X% trolamine salicylate cream compared with a placebo cream identical in smell and appearance, for subjects with osteoarthritis in their hands. This was a one-application, randomized, double-blind, placebo-controlled, parallel study conducted in 81 patients. Pain and stiffness were assessed in the morning upon subjects' awakening (baseline) and at 30, 45, and 120 min after a 4-min rubbing application. Analgesic response was determined using the sum of pain intensity differences (SPID) and the sum of stiffness intensity differences (SSID); the sum across the observation points derived from a pain/stiffness rating scale. Trolamine salicylate was significantly superior to the placebo in improving SPID (p = 0.0492) and in improving SSID scores for both hands (p = 0.0283). Treatment differences in absolute pain and stiffness scores were significant (p |Ml 0.05) at 45 min after application. A 10|X% trolamine salicylate cream was shown to be safe and effective for the temporary relief of minor pain and stiffness associated with osteoarthritis in the hands. This formulation has no smell or counter-irritating properties; patient acceptability was good.

PubMed Disclaimer

LinkOut - more resources